Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter randomized double-blind Phase 3b trial of saxagliptin added to insulin (± metformin) in type 2 diabetes mellitus
2008-001089-10Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of saxagliptin in type 2 diabetes mellitus (T2DM), sponsored by Bristol Myers Squibb. Started Oct 2008; status: completed.
02
Drugs
saxagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-001089-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001089-10.